Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
P013 (pertuzumab biosimilar)
i
Other names:
P013
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
CinnaGen
Drug class:
HER2 dimerization inhibitor
Related drugs:
‹
pertuzumab (102)
pertuzumab/trastuzumab/hyaluronidase-zzxf (3)
QL1209 (pertuzumab biosimilar) (1)
pertuzumab (102)
pertuzumab/trastuzumab/hyaluronidase-zzxf (3)
QL1209 (pertuzumab biosimilar) (1)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login